CliffBio
small molecule

HYDROCORTISONE BUTYRATE

HYDROCORTISONE BUTYRATE

Loss of exclusivity—loss of exclusivity
CompanyTaro Pharmaceutical Industries →See this company's full patent-cliff portfolio

Drug detail

Brand nameHYDROCORTISONE BUTYRATE
Active ingredientHYDROCORTISONE BUTYRATE
Strength0.1%
Dosage formSOLUTION
RouteTOPICAL
ModalitySmall molecule
FDA approvalJanuary 2004
Marketing statusRX

More from Taro Pharmaceutical Industries

Source: FDA Orange Book, layered on the CliffBio company graph. Cliff dates are the loss of exclusivity; estimates are projections, not legal advice.